Dr. Agarwal's Health Care Limited

Dr. Agarwal's Health Care Limited

AGARWALEYE.NS
Dr. Agarwal's Health Care LimitedIN flagNational Stock Exchange of India
497.85
INR
+16.30
- -
157.81BMarket Cap
Dr. Agarwal's Health Care Limited
AGARWALEYE.NS
(National Stock Exchange of India)

Recent

price

497.85

P/E

ratio

- -

div

yld

- -

ROIC.AI

2022
2023
2024
2025
2026
TTM
FRC
22.01
32.18
42.03
57.4
- -
49.97
Revenue per Share
1.19
2.98
2.63
2.8
- -
3.27
Basic EPS, GAAP
5.2
7.38
10.95
11.98
- -
- -
Free Cash Flow per Basic Share
- -
0.01
0.02
0.03
- -
- -
Dividend per Share
-5.86
-3.05
-0.57
-5.15
- -
1
Book Value per Share
1.49
5.31
20.57
24.65
- -
30.55
Tangible Book Value per Share
316
316
316
298
- -
316
Basic Weighted Avg Shares
6,953
10,165
13,277
17,110
20,801
15,814
Sales/Revenue/Turnover
13.81
15.11
15.2
13.19
14.1
14.23
Operating Margin (%)
940
1,283
1,704
2,307
2,762
2,084
Depreciation Expense
377
941
831
835
1,332
1,035
Net Income, GAAP
23.96
- -
32.38
30.97
32.38
32.48
Effective Tax Rate (%)
5.42
9.26
6.26
4.88
6.4
6.54
Profit Margin (%)
215
89
3,588
3,163
1,115
1,115
Working Capital
5,555
7,617
8,354
8,075
9,514
9,514
LT Debt
2,338
6,591
13,795
19,268
21,197
21,197
Total Equity
- -
- -
7.11
5.96
6.52
4.99
Return on Invested Capital (%)
- -
- -
15.26
14.19
15.48
11.77
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
1,148
LT Borrowings
- -
- -
1,333
LT Finance Leases
- -
- -
8,181
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
- -
317
Market Capitalization
159,878
160,099
128,649

Working Capital

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
- -
- -
5,730
Cash, Cash Equivalents & STI
- -
- -
2,950
Accounts Receivable, Net
- -
- -
1,609
Inventories
- -
- -
940
Total Current Liabilities
- -
- -
4,615
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
1,148
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
10.01%
Free Cash Flow
- -
- -
45.32%
Net Income, GAAP
- -
- -
59.59%
Sales/Revenue/Turnover
- -
- -
21.57%
Total Cash Common Dividend
- -
- -
37.97%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
13,277
2025
4,035
4,155
4,307
4,602
17,110
2026
4,874
- -
5,299
5,641
20,801

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
2.63
2025
0.38
- -
0.71
1.04
2.8
2026
0.95
- -
1.07
1.25
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.02
2025
- -
- -
- -
- -
0.03
2026
- -
- -
- -
- -
- -
Business
Dr. Agarwal's Health Care Limited operates as a specialized eye care company providing comprehensive ophthalmology services and products. Its core offerings include cataract surgeries, refractive surgeries, corneal, retinal, glaucoma, squint, and oculoplasty surgeries; consultations; clinical investigations; diagnoses; and non-surgical treatments. The company also markets optical products such as contact lenses, accessories, and eye-care-related pharmaceuticals. It operates a hub-and-spoke model with tertiary centers including centers of excellence in Chennai, Tirunelveli, and Cuttack, supported by secondary and primary centers. Founded in 2010 and headquartered in Chennai, India, Dr. Agarwal's Health Care has expanded its geographic presence into Telangana, Karnataka, and several other Indian states. The company serves a broad customer base requiring comprehensive eye care across surgery, diagnostics, and retail optical services. Recent major developments include the approved merger of its listed parent company Dr. Agarwal's Health Care Limited with its subsidiary Dr. Agarwal's Eye Hospital Ltd to create a simpler and more efficient group structure aimed at unlocking combined business potential. Additionally, the company secured significant funding in 2025, including a loan of approximately $31 million to support expansion in India and emerging markets. These strategic moves reflect the company's commitment to scaling operations and enhancing service delivery across its comprehensive eye care segments. Overall, Dr. Agarwal's Health Care Limited is a leading single-specialty healthcare provider in ophthalmology, combining surgical and non-surgical eye care with retail optical products, supported by a network of specialized facilities predominantly in India and select international markets. It continues to invest in growth through strategic mergers and funding to consolidate its market position and advance innovation in eye care services.